patient assistance programs leadership board of directors executive committee our work antimicrobial resistance our work in hepatitis c the impact of diabetes oncology how we operate code of conduct our values and standards our values and standards for external business partners compliance privacy transparency and privacy internet privacy policy cookie privacy commitment cross border policy employment privacy & data protection diversity employee diversity supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions access and affordability access to investigational medicines innovation quality and safety sales and marketing responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories living with breast cancer health literacy a point of view by julie gerberding m.d. m.p.h. meet paige cramer merck releases 2015 2016 corporate responsibility report how merck animal health helped to curb a new strain of civ women in science 2016 merck fellowship for global health meet daria hazuda a point of view by dr. jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes the mrl postdoctoral research fellow program living with type 2 diabetes it s personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer may is for mothers 2016 melanoma ... never walk alone be safe in the sun america s diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w. merck heart disease guided by research inspired by hope why animal health matters merck turns 125 cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer s disease living with hiv meet jason cheung hepatitis c a medical and social diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c. difficile beyond tired so are they ... meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health 2014 corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hiv aids fasting and diabetes merck s rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma ... never walk alone be safe in the sun may is for mothers bone health awareness america s diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event ebola outbreak everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials bridging the gap in diabetes care merck for mothers pep talk closing the circle on rabies desafiando la diabetes understanding diabetes helping empower women living with hiv diabetes and travel vaccines our history our legacy the impact of cancer making a difference products products products vaccines prescription products & prescribing information oncology animal health product patents authorized distributors vaccine contracted distributors research research research our people our culture our r & d process what we re working on pipeline clinical trials invent with us licensing licensing business development & licensing bd & l contacts news & events newsroom newsroom newsroom news releases prescription medicine news consumer care news vaccine news research & development news corporate news financial news corporate responsibility news animal health news information centers ebola hepatitis c oncology company statements media center company snapshot social media careers careers careers united states application tips life at merck diversity military functional opportunities internships & co ops entry level & rotation programs career choices benefits canada msd worldwide investors investors investors corporate governance proxy statement product pipeline webcasts & presentations financial reports annual reports and proxy statements quarterly financials sec filings stock information stock quote stock chart historical price lookup investment calculator dividend history stock splits mergers & spin offs joint ventures stockholder services contact us information request sign up for email alerts menu menu a few words from our chairman and ceo ken frazier watch video the impact of cancer while global cancer cases continue to rise around the world the fight is personal not only for patients and their loved ones but also for the scientific community . learn more lung cancer lung cancer is the most common cancer worldwide . learn more predicting progress the evolution of cancer research a point of view by dr. roger dansey head of merck s oncology late stage development program learn more our work in immuno oncology we are investing significant resources to develop innovative oncology medicines to help people living with cancer worldwide . learn more new approaches to fighting cancer merck scientists discuss the role of the immune system in cancer research . learn more hmo.ppo.hdhp . only 1 in 4 people know the difference.do you learn more from merck s julie gerberding merck turns 125 celebrating a legacy of invention that continues to fuel our quest to cure . read more previous next latest news read more social merck connect with us other merck sites merck for mothers merckhelps clinical trials corporate responsibility merck corporate responsibility website transparency disclosures california supply chains act merck animal health merck manuals merck engage merck connect reimbursement support and patient assistance programs univadis a service of merck subsidiary aptus health copyright 2009 2016 merck sharp & dohme corp. a subsidiary of merck & co. inc. all rights reserved . forward looking statement privacy terms of use site map close forward looking statement forward looking statement of merck & co. inc. kenilworth nj usa this website of merck & co. inc. kenilworth nj usa the company includes forward looking statements within the meaning of the safe harbor provisions of the united states private securities litigation reform act of 1995 . these statements are based upon the current beliefs and expectations of the company s management and are subject to significant risks and uncertainties . there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful . if underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forward looking statements . risks and uncertainties include but are not limited to general industry conditions and competition ; general economic factors including interest rate and currency exchange rate fluctuations ; the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally ; global trends toward healthcare cost containment ; technological advances new products and patents attained by competitors ; challenges inherent in new product development including obtaining regulatory approval ; the company s ability to accurately predict future market conditions ; manufacturing difficulties or delays ; financial instability of international economies and sovereign risk ; dependence on the effectiveness of the company s patents and other protections for innovative products ; and the exposure to litigation including patent litigation and or regulatory actions . the company undertakes no obligation to publicly update any forward looking statement whether as a result of new information future events or otherwise . additional factors that could cause results to differ materially from those described in the forward looking statements can be found in the company s 2015 annual report on form 10 k and the company s other filings with the securities and exchange commission sec available at the sec s internet site www.sec.gov . no duty to update the information contained in this website was current as of the date presented . the company assumes no duty to update the information to reflect subsequent developments . consequently the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date . about us about us corporate responsibility reimbursement support and patient assistance programs leadership board of directors executive committee our work antimicrobial resistance our work in hepatitis c the impact of diabetes oncology how we operate code of conduct our values and standards our values and standards for external business partners compliance privacy transparency and privacy internet privacy policy cookie privacy commitment cross border policy employment privacy & data protection diversity employee diversity supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions access and affordability access to investigational medicines innovation quality and safety sales and marketing responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories living with breast cancer health literacy a point of view by julie gerberding m.d. m.p.h. meet paige cramer merck releases 2015 2016 corporate responsibility report how merck animal health helped to curb a new strain of civ women in science 2016 merck fellowship for global health meet daria hazuda a point of view by dr. jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes the mrl postdoctoral research fellow program living with type 2 diabetes it s personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer may is for mothers 2016 melanoma ... never walk alone be safe in the sun america s diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w. merck heart disease guided by research inspired by hope why animal health matters merck turns 125 cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer s disease living with hiv meet jason cheung hepatitis c a medical and social diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c. difficile beyond tired so are they ... meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health 2014 corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hiv aids fasting and diabetes merck s rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma ... never walk alone be safe in the sun may is for mothers bone health awareness america s diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event ebola outbreak everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials